Completed Phase 1/2 Study of AOC 1020 in Participants With Facioscapulohumeral Muscular Dystrophy (FSHD) NCT05747924 Conditions Atrophies, Facioscapulohumeral, Atrophy, Facioscapulohumeral, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +33 more Locations University of California Los Angeles — Los Angeles, California, United States Stanford University — Palo Alto, California, United States University of California San Diego — San Diego, California, United States University of Colorado — Denver, Colorado, United States View all 17 locations View more locations Show fewer locations Loading locations... View Trial Details
Active, Not Recruiting Phase 2 Open-label Extension Study of AOC 1020 in Participants With Facioscapulohumeral Muscular Dystrophy (FSHD) NCT06547216 Conditions Atrophies, Facioscapulohumeral, Atrophy, Facioscapulohumeral, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +33 more Locations University of California Los Angeles — Los Angeles, California, United States Stanford University — Palo Alto, California, United States University of California San Diego — San Diego, California, United States University of Colorado — Denver, Colorado, United States View all 17 locations View more locations Show fewer locations Loading locations... View Trial Details
